GO:0051381 histamine binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051381 histamine binding is a molecular_function term describing the selective, non-covalent interaction of a protein or biomolecule with histamine, a physiologically active amine released from mast cells during allergic reactions.
• The best structurally characterized histamine-binding proteins are tick lipocalins, which possess two distinct binding cavities and sequester host histamine at the tick-host interface.
• Histamine binding to its cognate G protein-coupled receptors (H1R-H4R) is protonation-dependent, and the protonation state of the imidazole ring strongly influences receptor affinity.
• Histamine binding underlies migraine pathophysiology, stress-related neuroimaging signals, and H4R-mediated immune cell chemotaxis.
• Species differences in histamine binding, such as the zebrafish H1R second extracellular loop, reveal evolutionarily divergent pharmacophores.
• EDITGENE supports histamine binding research with CRISPR knockout, point-mutation, knock-in, overexpression cell models, and CRISPR library screening.
Description
Histamine binding (GO:0051381) is a molecular_function term defined as the binding to histamine, a physiologically active amine found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans. Histamine exerts its biological effects by docking into specific pockets of target proteins, most prominently the four histamine receptor subtypes (H1R, H2R, H3R, H4R), but also into non-receptor proteins such as tick histamine-binding lipocalins. The interaction is non-covalent and depends on the protonation state of the histamine imidazole ring, which dictates electrostatic complementarity with acidic residues in the binding pocket. For researchers, histamine binding is a tractable molecular event that bridges allergy, neurobiology, and immunology. Histamine binding to H1R is central to migraine mechanisms and to stress-related neuroimaging phenotypes. Histamine binding to H4R drives chemotaxis of immune cells and is a validated drug target. In ectoparasites, histamine-binding proteins evolved to neutralize host histamine, illustrating how binding function can be repurposed for immune evasion. Because histamine binding is a molecular_function rather than a pathway, its study requires structural, pharmacological, and genetic tools. CRISPR-based cell models allow researchers to delete or mutate the genes encoding histamine-binding proteins and to measure the consequences on binding affinity, downstream signaling, and disease-relevant phenotypes.
histamine binding At A Glance
| GO ID | GO:0051381 |
|---|---|
| GO term | histamine binding |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Selective non-covalent interaction with histamine, a physiologically active amine released from mast cells during allergic reactions |
| Representative proteins | Histamine receptor subtypes H1R, H2R, H3R, H4R; tick histamine-binding lipocalins |
| Binding determinants | Protonation state of the histamine imidazole ring and electrostatic complementarity with the binding pocket |
| Disease relevance | Allergy, migraine, stress-related disorders, immune cell chemotaxis |
| Research methods | Structural biology, radioligand binding, mutagenesis, CRISPR cell models, neuroimaging |
What Is GO:0051381?
GO:0051381 histamine binding describes the molecular function of selectively and non-covalently interacting with histamine, a biogenic amine synthesized from histidine and stored in mast cells and other cells. The term captures the binding event itself, not the downstream signaling or metabolic fate of histamine. It is classified under molecular_function in the Gene Ontology and applies to any protein or biomolecule that physically associates with histamine, including G protein-coupled histamine receptors and histamine-sequestering lipocalins.
Why Is histamine binding Important in Cell Biology?
Histamine binding is important because it is the first committed step in histamine signaling and in histamine sequestration. Every physiological and pathological effect of histamine, from vasodilation and bronchoconstriction in allergy to migraine pain and immune cell recruitment, requires histamine to bind a protein partner. Understanding the structural and electrostatic rules of histamine binding enables rational drug design, explains species-specific pharmacology, and provides a molecular readout for genetic perturbation experiments.
• Histamine binding to H1R is a core mechanism in migraine and allergic responses.
• Histamine binding to H4R mediates immune cell chemotaxis and is a drug target.
• Protonation of histamine controls its binding affinity to H1R, linking pH and electrostatics to pharmacology.
• Tick histamine-binding proteins demonstrate that histamine binding can be an immune-evasion strategy.
• Histamine binding signals are detectable by neuroimaging in stress-related disorders.
• The H2R agonistic binding site has been modeled using serine protease catalytic triads, informing receptor pharmacology.
• Zebrafish H1R pharmacology reveals the second extracellular loop as a determinant of histamine binding.
• Histamine binding is a molecular_function that can be perturbed by CRISPR knockout or point mutation of receptor genes.
• Binding affinity measurements provide quantitative phenotypes for genetic screens.
• Histamine-binding proteins are candidate therapeutic agents or targets in inflammation and parasitology.
Molecular Mechanism of histamine binding
Histamine protonation and electrostatic recognition
In simple terms: Histamine carries a positive charge under physiological conditions, and that charge helps it stick to acidic pockets in proteins.
Histamine binding is strongly influenced by the protonation state of its imidazole ring. Computational analysis of histamine protonation effects on H1R binding shows that the charged form of histamine forms favorable electrostatic interactions with acidic residues in the receptor binding pocket, and that protonation modulates the calculated binding energy. This electrostatic complementarity is a general principle for histamine recognition by receptor proteins.
Binding cavity architecture in histamine receptors
In simple terms: Histamine receptors have a pocket shaped to fit histamine, and the exact shape differs between receptor subtypes.
The histamine H2 receptor agonistic binding site has been modeled using the catalytic triad of serine proteases as a template, suggesting that a network of polar residues positions histamine for activation. Structural insights into the human histamine H4 receptor reveal how agonists bind and how receptor selectivity is achieved, providing a template for understanding subtype-specific histamine binding. The zebrafish H1 receptor requires its second extracellular loop for histamine binding, demonstrating that regions outside the canonical orthosteric pocket contribute to the binding event.
Two-cavity binding in tick lipocalins
In simple terms: Some tick proteins trap histamine in two separate pockets, like a double lock.
Tick histamine-binding proteins are lipocalins with a second binding cavity, an unusual structural feature that allows them to sequester histamine with high efficiency. These proteins are released at the tick-host interface and neutralize host histamine, and their histamine-binding function has been proposed as a basis for therapeutic agents. This illustrates that histamine binding is not restricted to G protein-coupled receptors.
Receptor activation and downstream signaling
In simple terms: Once histamine is bound, the receptor changes shape and triggers signals inside the cell.
Histamine binding to H1R and H4R initiates conformational changes that activate G protein-dependent signaling. Structural analysis of H4R agonist binding provides a framework for understanding how the binding event is coupled to receptor activation and selectivity. In the zebrafish H1R, the second extracellular loop influences histamine binding and pharmacology, indicating that binding and activation are structurally coupled.
Histamine binding in neurobiology and stress
In simple terms: In the brain, histamine binding to receptors contributes to arousal, stress responses, and migraine.
Histamine binding is relevant to migraine, where histamine and its receptors participate in trigeminovascular mechanisms. Histamine neuroimaging in stress-related disorders shows that histamine binding and receptor availability can be measured in vivo, linking molecular binding events to brain phenotypes. These studies position histamine binding as a translational bridge between molecular pharmacology and clinical neuroscience.
Key Genes Involved in GO:0051381 histamine binding
The following genes and proteins are directly implicated in histamine binding or in the pharmacological characterization of histamine-binding sites.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HRH1 | Histamine receptor H1; binds histamine to mediate allergy and migraine signaling | Target for antihistamines and migraine research |
| HRH2 | Histamine receptor H2; binds histamine to stimulate gastric acid secretion | Modeled agonistic binding site informs receptor pharmacology |
| HRH3 | Histamine receptor H3; presynaptic autoreceptor binding histamine | Neuromodulation and stress-related research |
| HRH4 | Histamine receptor H4; binds histamine to drive immune cell chemotaxis | Structural and drug discovery target |
| HBP1 | Tick histamine-binding protein; lipocalin with two histamine-binding cavities | Model for histamine sequestration and therapeutic design |
| HBP2 | Tick histamine-binding protein family member | Comparative structural studies of histamine binding |
| HBP3 | Tick histamine-binding protein family member | Ligand-binding cavity evolution |
| HBP4 | Tick histamine-binding protein family member | Lipocalin-based histamine neutralization |
| H1R (zebrafish) | Zebrafish histamine H1 receptor; binds histamine with species-specific pharmacology | Second extracellular loop determinants of binding |
| H2R | Histamine H2 receptor; binds histamine via a polar residue network | Catalytic triad model of agonistic binding |
| H4R | Human histamine H4 receptor; binds histamine and selective agonists | Cryo-EM and structural pharmacology |
| H1R | Human histamine H1 receptor; binds histamine in protonation-dependent manner | Computational protonation analysis |
| HDC | Histidine decarboxylase; synthesizes histamine | Upstream regulator of histamine availability for binding |
| HNMT | Histamine N-methyltransferase; metabolizes histamine | Controls histamine levels available for binding |
| DAO | Diamine oxidase; degrades histamine | Regulates histamine pools in tissues |
| GNAQ | Gq alpha subunit; transduces H1R signals after histamine binding | Downstream readout of histamine binding |
| GNAS | Gs alpha subunit; transduces H2R signals after histamine binding | Downstream readout of histamine binding |
How Is histamine binding Regulated?
Histamine binding is regulated at multiple levels. The availability of histamine is controlled by synthesis via histidine decarboxylase and degradation by histamine N-methyltransferase and diamine oxidase. At the protein level, the protonation state of histamine modulates its binding affinity, as shown for H1R. Receptor expression levels and extracellular loop sequences, such as the second extracellular loop of the zebrafish H1R, further tune histamine binding. In stress-related disorders, neuroimaging indicates that histamine receptor availability changes in vivo, suggesting physiological regulation of histamine binding sites.
histamine binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HRH1 | Migraine and allergy | HRH1 knockout and point-mutation cell lines for binding assays |
| HRH4 | Immune cell chemotaxis and inflammation | HRH4 knock-in reporter cells for structural pharmacology |
| HRH2 | Gastric acid secretion and receptor pharmacology | HRH2 point-mutation models of the agonistic binding site |
| HRH3 | Stress-related disorders | HRH3 knockout neurons for neuroimaging correlation |
| HBP1 | Tick-host immune evasion | Recombinant lipocalin overexpression for histamine sequestration assays |
Histamine binding in migraine
Histamine and its receptors are implicated in migraine pathophysiology. Histamine binding to H1R and related receptors contributes to trigeminovascular activation and pain signaling, and antihistaminergic strategies have been explored for migraine. Understanding the molecular details of histamine binding supports the development of receptor-selective therapeutics.
Histamine binding in stress-related disorders
Histamine neuroimaging in stress-related disorders demonstrates that histamine binding and receptor availability can be quantified in the living brain. These findings link molecular histamine binding events to stress-related phenotypes and support further genetic and pharmacological studies.
Histamine binding in immune and inflammatory disease
Histamine binding to H4R drives chemotaxis of immune cells and is a validated target in inflammatory disease. Structural insights into H4R agonist binding provide a basis for designing selective modulators that interfere with histamine binding.
Histamine binding in ectoparasite-host interactions
Tick histamine-binding proteins sequester host histamine and are potential therapeutic agents or vaccine targets. Their two-cavity lipocalin architecture illustrates how histamine binding can be exploited in parasitology and drug design.
From histamine binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HRH1 abolish histamine binding and signaling? | HRH1 knockout cell line |
| Which residue determines histamine affinity? | Point-mutation knock-in of the binding pocket residue |
| Can a tagged receptor report histamine binding in live cells? | Tagged knock-in of HRH1 with a fluorescent tag |
| Does overexpression of a histamine-binding lipocalin sequester histamine? | Overexpression cell model of HBP1 |
| Which genes modify histamine binding phenotypes? | CRISPR library screening in histamine-responsive cells |
| Does species-specific extracellular loop swapping change binding? | Knock-in of zebrafish H1R loop into human HRH1 |
How to Study the histamine binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding assay | Affinity and competition at histamine-binding sites | Receptor pharmacology |
| Fluorescent histamine binding | Real-time binding in live cells | Tagged knock-in receptor studies |
| Cryo-EM | Atomic structure of receptor-histamine complexes | H4R agonist binding |
| Computational protonation analysis | Effect of histamine charge on binding energy | H1R binding modeling |
| PET neuroimaging | In vivo histamine receptor availability | Stress-related disorders |
| Site-directed mutagenesis | Residue-level contributions to binding | Binding pocket mapping |
| CRISPR knockout | Loss-of-function phenotype for a histamine-binding gene | Causal gene validation |
| CRISPR library screening | Genome-wide modifiers of histamine binding | Target discovery |
Radioligand and fluorescent binding assays
Direct binding assays using radiolabeled or fluorescent histamine analogs quantify affinity and competition at histamine-binding proteins. These assays are the standard for measuring the consequences of CRISPR edits in receptor genes.
Structural biology and computational modeling
Cryo-EM and X-ray structures of histamine receptors, combined with computational protonation analysis, reveal the atomic determinants of histamine binding. Homology modeling based on serine protease catalytic triads has been used to propose H2R agonistic binding sites.
Neuroimaging of histamine binding
PET and related neuroimaging approaches measure histamine receptor availability in vivo, providing a translational readout of histamine binding in stress-related disorders.
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, and knock-in models allow causal testing of histamine-binding genes. Combining these models with binding assays and signaling readouts links genotype to molecular function.
How CRISPR Can Be Used to Study GO:0051381 histamine binding
Knockout
CRISPR knockout of HRH1, HRH2, HRH3, or HRH4 eliminates the corresponding histamine-binding protein, providing a clean background to measure residual binding and to validate antibody specificity. Knockout models are essential for causal claims about histamine binding in disease phenotypes.
Point Mutation
Point mutation of residues in the histamine-binding pocket, such as acidic residues predicted to interact with protonated histamine, allows precise testing of electrostatic contributions to binding affinity. Point-mutant cell lines are ideal for comparing wild-type and mutant binding curves.
Knock-in
Knock-in of fluorescent or affinity tags into endogenous histamine receptor loci enables live-cell imaging and pull-down of histamine-binding complexes. Knock-in of species-specific loops, such as the zebrafish H1R second extracellular loop, can dissect species differences in histamine binding.
Overexpression
Overexpression of histamine-binding proteins, including tick lipocalins, allows production of recombinant protein for structural and biophysical studies and for testing histamine sequestration. Overexpression in mammalian cells also supports high-throughput binding screens.
How EDITGENE Supports histamine binding Research
Researchers studying histamine binding-related genes often need to determine whether a candidate gene is causally involved in histamine recognition, signaling, or sequestration. EDITGENE provides publication-ready CRISPR cell models and screening services that let you move from correlation to causation with validated reagents.
Contact EDITGENE today to design your custom CRISPR model for histamine binding research.
Frequently Asked Questions About histamine binding
What is histamine binding?
Histamine binding (GO:0051381) is the molecular function of selectively and non-covalently interacting with histamine, a physiologically active amine released from mast cells during allergic reactions.
What genes are involved in histamine binding?
Key genes include HRH1, HRH2, HRH3, and HRH4, which encode histamine receptors, as well as tick histamine-binding protein genes such as HBP1.
Which GO term describes histamine binding?
The Gene Ontology term is GO:0051381, named histamine binding, under the molecular_function ontology.
How does histamine protonation affect binding?
Computational analysis shows that the protonated form of histamine forms favorable electrostatic interactions with H1R, modulating binding energy.
What are tick histamine-binding proteins?
They are lipocalins with a second binding cavity that sequester host histamine and are studied as potential therapeutic agents.
Is histamine binding involved in migraine?
Yes, histamine and its receptors are implicated in migraine pathophysiology, and histamine binding to H1R contributes to trigeminovascular mechanisms.
Can histamine binding be measured in the brain?
Histamine neuroimaging in stress-related disorders allows in vivo measurement of histamine receptor availability.
What is the structure of the H4 receptor histamine binding site?
Structural insights into human H4R agonist binding reveal the determinants of receptor selectivity and histamine recognition.
How is the zebrafish H1 receptor used in histamine binding research?
The zebrafish H1R reveals that the second extracellular loop is involved in histamine binding, highlighting species-specific pharmacophores.
How can CRISPR help study histamine binding?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of histamine-binding genes and their disease relevance.
Conclusion
Histamine binding (GO:0051381) is a molecular_function that underpins allergy, migraine, stress-related neurobiology, and immune cell chemotaxis. Structural and computational studies have defined the electrostatic and cavity determinants of histamine recognition, while tick lipocalins show that histamine binding can be repurposed for immune evasion. CRISPR-based cell models now make it possible to test the causal role of histamine-binding proteins in disease-relevant phenotypes. EDITGENE provides the knockout, point-mutation, knock-in, overexpression, and screening tools needed to advance this research.
References
- 1. Mans BJ. 2005. Tick histamine-binding proteins and related lipocalins: potential as therapeutic agents.. Curr Opin Investig Drugs 6(11):1131-5 PMID: 16312134
- 2. Paesen GC et al.. 2000. Tick histamine-binding proteins: lipocalins with a second binding cavity.. Biochim Biophys Acta 1482(1-2):92-101 PMID: 11058751
- 3. Conrad M et al.. 2023. Computational Analysis of Histamine Protonation Effects on H(1)R Binding.. Molecules 28(9) PMID: 37175183
- 4. Yuan H et al.. 2018. Histamine and Migraine.. Headache 58(1):184-193 PMID: 28862769
- 5. Fukudo S et al.. 2022. Histamine Neuroimaging in Stress-Related Disorders.. Curr Top Behav Neurosci 59:113-129 PMID: 35156186
- 6. Nederkoorn PH et al.. 1994. A new model for the agonistic binding site on the histamine H2-receptor: the catalytic triad in serine proteases as a model for the binding site of histamine H2-receptor agonists.. J Mol Graph 12(4):242-56 PMID: 7696215
- 7. Im D et al.. 2023. Structural insights into the agonists binding and receptor selectivity of human histamine H(4) receptor.. Nat Commun 14(1):6538 PMID: 37863901
- 8. McNaught-Flores DA et al.. 2024. Pharmacological Characterization of the Zebrafish (Danio Rerio) Histamine H(1) Receptor Reveals the Involvement of the Second Extracellular Loop in the Binding of Histamine.. Mol Pharmacol 105(2):84-96 PMID: 37977823
